Lead compounds for antifungal drug development are urgently needed because invasive fungal infections are an important cause of morbidity and mortality in immunocompromised patients. Here, a high-throughput screening assay for small molecules that cause yeast cell lysis is described. The assay is based on the detection of the intracellular enzyme adenylate kinase in the culture medium as a reporter of yeast cell lysis. Features of the assay protocol include 1) the ability to detect cell lysis at drug concentrations that cause no apparent growth defect, 2) specificity for fungicidal molecules, 3) a simple 1-plate, add-and-read protocol using a commercially available adenylate kinase assay kit, 4) short, 5-h incubation time, and 5) low cost. The assay is applicable to the model yeast Saccharomyces cerevisiae and to Candida albicans, the most common human fungal pathogen. The adenylate kinase assay is validated in a pilot screen of 4505 compounds. Consistent with its specificity for fungicidal molecules, the largest class of molecules identified in 2 libraries of known bioactive molecules targeted the plasma membrane. Fungistatic compounds are not detected by the assay. Adenylate kinase-based screening appears to be a useful approach to the direct identification of small molecules that kill yeast cells. (Journal of Biomolecular Screening 2008:657-664)
INTRODUCTION
T HE DEVELOPMENT OF NEW ANTIFUNGAL DRUGS is an important area of current anti-infective research because the incidence of invasive fungal infections is increasing, particularly in immunocompomised patients. 1 To address this need, the design of novel high-throughput screening (HTS) methods for the identification of antifungal lead compounds is an area of active research. [2] [3] [4] [5] Toward this end, we have designed and developed an HTScompatible assay to detect molecules that disrupt yeast cell integrity. The assay is based on the release of the intracellular enzyme adenylate kinase (AK) into the culture medium as a reporter of yeast cell lysis. AK activity is then detected by a commercially available luminescent assay in which AK-generated adenosine triphosphate activates luciferase. Extracellular AK activity has been used previously to detect autolysis of yeast strains in the brewing industry, but to our knowledge, it has not been applied to drug discovery. 6 As detailed below, the AK assay has a number of attractive features. First, it specifically detects fungicidal molecules. Fungicidal molecules are a particularly valuable class of antifungal drugs because the compromised immune systems of most patients with invasive fungal infections cannot help clear the infection, and therefore, successful treatment is highly dependent on the efficacy of the antifungal drug. 7 Second, the AK assay detects the lysis of a small number of cells and therefore can identify fungilytic molecules at concentrations well below those that cause growth defects. Third, the assay is compatible with the model yeast Saccharomyces cerevisiae and the most common human fungal pathogen, Candida albicans. Fourth, the AK assay is operationally simple, employing an add-and-read protocol using a single microplate. In this report, we describe the characteristics of the AK assay as well as its application to a pilot scale HTS of 4505 compounds.
Reagents, chemicals, and antifungal compounds
All reagents and compounds were obtained from Sigma (St. Louis, MO) unless otherwise indicated. ToxiLight AK assay kits were obtained from Lonza (Basel, Switzerland) and reconstituted according to the manufacturer's instructions. Caspofungin acetate (CAS; Merck, Whitehouse Station, NJ), fluconazole (FLC; Pfizer, New York, NY), and amphotericin B (AMB; X-Gen, Big Flats, NY) were obtained from the Strong Memorial Hospital Formulary. Retesting of positive scoring compounds was performed using fresh stocks of compound. Antifungal stock solutions were prepared in DMSO and stored at -20 °C according to CLSI recommendations. 9 Propidium iodide (PI) was obtained from Invitrogen/Molecular Probes (Carlsbad, CA).
Manual, 96-well plate adenylate kinase assay protocol
A single yeast colony stored on a YPD plate (plated from a frozen stock less than 2 wk prior) was used to inoculate a 3-mL YPD starter culture and incubated overnight with shaking at 25 °C. The resulting culture was diluted 1/10,000 into fresh YPD (10-100 mL) and grown into mid-logarithmic phase (OD 600 < 2.0) with shaking at 25 °C. The cells were harvested by centrifugation (1000g), washed with an equal volume of sterile water, and suspended in 2X YPD with a final cell density of 0.2 OD 600 units. Fifty microliters of this culture was added to the wells of a standard clear 96-well plate (33570; Corning, Corning, NY) using a multichannel pipettor. Fifty microliters of drug solution or DMSO control was added to each well with a multichannel pipettor. The covered plates were incubated without shaking in a humidified incubator at 25 °C for 4 h and then equilibrated at ambient temperature for 1 h. 
384-well automated AK HTS screening protocol
Yeast cultures were cultivated and prepared as described in the 96-well protocol. Twenty-five microliters of yeast culture was added to each well of a white-walled, opaque 384-well plate (Corning, 3704) using a WellMate liquid-handling apparatus (Hudson, NH). A total of 0.3 μL of library compound solutions (5 mg/mL in 100% DMSO) was added to each well using robotic pin transfer (Epson Robots, Carson, CA). Plates were incubated in a humidified incubator at 25 °C for 4 h and then equilibrated at ambient temperature for 1 h. Twenty-five microliters of freshly prepared ToxiLight reagent was added to each well using the WellMate apparatus. Luminescence was measured using an Envision plate reader with an ultra-high sensitivity detector (Perkin-Elmer, Waltham, MA).
HTS experiments
All robotic screening experiments were performed in 384-well format at the Institute of Chemistry and Cell Biology-Longwood (ICCB-L) at the Harvard Medical School, Boston, Massachusetts, using libraries listed in Table 1 and the 384-well protocol described immediately above (for full details of libraries, see http://iccb.med.harvard.edu). All libraries were screened in duplicate using the 384-well AK assay protocol, with DMSO (1% final concentration) and caspofungin (600 ng/mL) controls added manually (4 wells each per plate). Two plates with alternating wells of DMSO-negative control and caspofungin-positive control were processed during each screening run and gave Z′ scores between 0.7 and 0.8. RLU from the experimental wells were compared with the negative control wells on the same plate to determine the fold increase in AK activity. The average RLU for each compound was calculated from the duplicate runs, and the average was used to score compounds. Compounds were scored as positive if the average ratio of treated to untreated RLU was 5-fold or greater. Positives were classified as weak (5-to 10-fold), medium (10-to 20-fold), or strong (>20-fold). Screening data were processed using Microsoft Excel Software. A list of all positive compounds from libraries of known bioactive molecules is provided in Supplemental Table 1 (online at http://jbx.sagepub .com/supplemental/). Forty-three AK-positive compounds were retested with fresh stocks of compound (5 mg/mL in 100% DMSO) using the 96-well format protocol; final drug concentrations were identical to those used in the primary screen (60 μg/mL). Two independent experiments were performed in quadruplicate for each retested compound. Compounds were classified as positive on retest if the ratio of RLU for treated and untreated wells was >5:1.
Assays of antifungal activity
Antifungal susceptibility testing of S. cerevisiae BY4741 was performed using a previously published modification of CLSI microbroth dilution protocol M27-A. 9,10 Endpoint growth assays were conducted using a protocol based on published procedures. 10, 11 Time-kill assays were performed as described by Ansehn and Nilsson, 12 with a single endpoint of 5 h. All assays were performed in triplicate on 2 or 3 separate days.
PI staining
BY4741 cells were treated with molecules as described in the 96-well plate AK assay protocol and then processed for PI staining using a published protocol. 13 Briefly, cells were harvested by centrifugation, washed with water, and resuspended in 100 μL of PI solution (0.005% in phosphate-buffered saline). The samples were incubated in the dark for 1 h and scored by fluorescence microscopy (DAPI filter). For each drug concentration, 2 wells (100 cells from each well) were scored on 2 separate days and compared with DMSO-treated wells from the same plate. The percentage of cells with nuclear staining was then determined.
RESULTS

AK release as a reporter of yeast cell lysis
To directly detect molecules that kill yeast cells in HTS format, we investigated the use of intracellular enzymes as reporters of yeast cell lysis. We initially examined alkaline phosphatase release, an assay that has previously been used to detect yeast cell lysis, 13 but we found it was not sufficiently sensitive or reproducible for HTS (data not shown). Therefore, we turned to AK release based on a report describing its use to detect lysis in brewing strains. 6 To test the feasibility of AK release as a reporter of yeast cell lysis, logarithmic phase S. cerevisiae BY4741 cells were incubated in YPD medium with 1% DMSO containing either 250 ng/mL CAS or no drug. CAS is a fungicidal antifungal that inhibits the synthesis of 1,3-β-glucan, a key component of the fungal cell wall. 14 After 5 h at 25 °C, >99% of the cells were inviable as judged by PI staining, and samples of culture medium were removed. The supernatant (100 μL) was cleared of cells by centrifugation (3000g) and treated with an equal volume of ToxiLight AK assay cocktail (Lonza). The AK reaction was incubated for 15 min at 25 °C, and luminescence was measured in a plate reader. As shown in Figure 1A , CAStreated cells released significant AK activity (3265 RLU), whereas DMSO-treated cells showed a low level of background AK activity (141 RLU). The addition of AK reagent to cell-free YPD solutions of CAS caused no increase in luminescence (data not shown). Similar levels of AK release in CAS-treated cells (Fig. 1A) were obtained when the drug incubation was carried out in a 96-well microplate (supernatant volumes were normalized by cell number to ensure that the same cell equivalents were assayed in culture flask and microplate experiments). The performance of both the drug treatment and AK reaction in the same 96-well microplate also gave results comparable to that obtained with cell-free supernatants (Fig. 1A) .
These results indicate that the AK assay detects yeast cell lysis and is compatible with microplate format using a simple, 1-plate, add-and-read protocol.
We next examined the effect of culture and AK reaction parameters on assay performance. To determine the effect of culture incubation temperature, we carried out the CAS exposures at 3 commonly used yeast incubation temperatures (25 °C, 30 °C, and 37 °C). AK activity released in the medium decreased 25% at 37 °C (Fig. 1B) , whereas there was little difference between experiments carried out at 25 °C and 30 °C. Because the AK detection assay was optimized for 25 °C by the manufacturer, 25°C was adopted as the temperature for both drug incubations and AK reactions for all subsequent experiments.
The nature of the growth medium also affected the performance of the assay. Rich medium (YPD) provided superior signal when compared with either standard synthetic yeast medium or RPMI 1640 tissue culture medium used in antifungal susceptibility testing. 9 For example, treatment of S. cerevisiae BY4741 cells with CAS (62.5 ng/mL) in YPD gave a 60-fold increase in AK activity relative to untreated controls ( Table 2) , whereas experiments in RPMI 1640 showed no increase over background (CAS treated: 67 RLU; untreated: 60 RLU). AK release was measurable over background in RPMI 1640 when the CAS concentration was increased to 250 ng/mL (CAS treated: 213 RLU; untreated: 60 RLU). In contrast, variation in medium pH between pH 6 and 7.5 had little effect on assay performance (data not shown). Therefore, we have used unbuffered YPD (pH 6) as the standard medium for the assay to minimize expense and additional processing.
The effect of initial cell inoculum on assay performance was also evaluated. As expected, the overall signal increased with increasing initial cell density, but initial cell densities greater than 1 × 10 6 cells/mL gave unacceptably variable results because of biphasic AK reaction curves (data not shown). Consequently, an initial cell density of 1 × 10 6 cells/mL was used for all subsequent experiments because it maximizes signal without compromising reproducibility.
To determine the optimal incubation time for drug exposure, S. cerevisiae BY4741 cells were treated with 5 mM caffeine, a weakly fungilytic molecule, 13 and AK activity was measured hourly over a 7-h time course. As shown in Figure 1C , the AK activity increases to a peak at 5 h and then declines, indicating that this incubation time will provide good sensitivity for weakly active molecules.
We also investigated the effect of AK reaction time on the overall luminescence signal. Toward this end, 120-min AK reaction progress curves were generated using S. cerevisiae cells treated with CAS (62.5 ng/mL) for 5 h at 25 °C, showing that AK activity smoothly increases over the 120-min period (Fig. 1D) . Beyond 120 min, well-to-well variability increases significantly, possibly because of differential evaporation during prolonged incubation (data not shown). The steady increase in signal provides a wide window of time during which samples can be processed; however, because the curves are not linear, each plate requires negative controls to compare wells to controls that have been incubated for similar lengths of time.
The extracellular AK activity induced by 3 other classes of clinically used antifungal drugs (AMB, 5-fluorocytosine, and FLC) was determined using S. cerevisiae BY4741 cells. We predicted that FLC and 5-fluorocytosine would induce very little AK release because they are fungistatic, whereas we expected AMB to induce AK release because it is fungicidal. Consistent with these expectations, the AK activity of supernatants from cultures treated with FLC or 5-fluorocytosine at the minimum inhibitory concentration (MIC; or at concentrations up to 10-fold greater than MIC, data not shown) was indistinguishable from cells treated with carrier solvent alone (Fig. 1E) . These data indicate that fungistatic molecules do not induce AK release. Surprisingly, AMB induced very little AK release using our standard 5-h protocol (Fig. 1E) . However, Liao and coworkers 15 had previously shown that AMB disrupted plasma membrane integrity only after 24 h of drug exposure. Consistent with their observations, BY4741 cells incubated with AMB for 24 h showed a 3.5-fold increase in AK release as compared with untreated control cells (357 RLU for AMB-treated cells v. 92 RLU for untreated cells). The fact that AK release corresponds with the timing of plasma membrane breakdown in AMB-treated cells supports the correlation of AK release with cell lysis.
Finally, we briefly tested the AK assay protocol using C. albicans, the most common human fungal pathogen. As shown in Figure 1F , C. albicans strain CAI-4 showed CAS-induced AK release using the same protocol used for S. cerevisiae, although the overall signal was lower compared with experiments with S. cerevisiae. This indicates that the AK assay is applicable to the direct screening of a pathogenic yeast.
Comparison of AK assay to established assays of antifungal activity
As our standard 96-well protocol, we adopted a procedure in which logarithmic-phase yeast cells (BY4741) at a cell density of 1 × 10 6 cells/mL were treated with drug in YPD at 25 °C for 5 h. AK assay cocktail was added and the luminescence measured after 15 min using a standard plate reader (see the Materials and Methods section for complete details). Using this protocol, we compared the performance of the AK assay to 3 standard assays of antifungal activity using CAS as a positive control. The most commonly used assay to screen molecules for antifungal activity is an endpoint, optical density-based growth assay. 11, 16 Therefore, we compared the AK activity to the growth assay using a 2-fold dilution series of CAS concentrations ranging from 2-fold greater than the MIC to 8-fold less than the MIC ( Table 2) . Statistically significant AK activity (p < 0.05, Student t-test) was detected at CAS concentrations 8fold less than the MIC, whereas the growth assay demonstrated a difference between treated and untreated cells only at the MIC ( Table 2) , indicating that the AK assay is more sensitive for the detection of molecules that cause cell lysis than an optical density-based growth assay. 10 We also compared the CAS-induced AK dose response to an alterative cell viability assay, PI staining. 13 Using fluorescence microscopy, we determined the percentage of PI staining cells at the CAS concentration described above ( Table 2) . A statistically significant increase in PI staining was observed 4-fold less than the MIC for CAS ( Table 2) , whereas a statistically significant increase in AK activity was observed 8-fold less than the MIC. Therefore, AK activity is slightly more sensitive than PI staining for the detection of lysed yeast cells. In addition, these data confirm that AK activity increases as the number of viable cells decreases. This correlation was confirmed further by single time point kill assays, as shown in Table 2 .
The lower limit of AK assay sensitivity is between 500 and 1000 lysed yeast cells/well
At less than 7.5 ng/mL CAS, the amount of AK released by CAS-treated cells was not significantly different from that released by untreated cells (data not shown), indicating that a 3-fold increase in AK release was the limit of detection for the AK assay ( Table 2) . To estimate the minimum number of lysed cells detectable by the AK assay, we treated S. cerevisiae BY4741 cells (1 × 10 7 cells as determined by hemacytometer) with CAS (250 ng/mL) and monitored cell viability by PI staining (samples were collected and stained every 15 min). Once ∼80% of the cells were dead (1 h), cell debris was removed by centrifugation and a 10-fold dilution series of the supernatants was prepared. The AK activity of the series was then measured, and the difference between treated and untreated cells was analyzed by Student t-test (Fig. 2) . A statistically significant difference in AK activity was detected at dilutions containing ∼800 or more lysed cell equivalents (p < 0.05).
This estimate of sensitivity is corroborated by comparison of PI staining to AK activity in the dose-response data ( Table  2 ). At 7.5 ng/mL CAS, the AK signal-to-background ratio is 3 and the number of PI staining cells per well is approximately 500 (0.5% of 1 × 10 5 cells/well). Based on these data, we estimate that the lower limit of detection for the AK assay is between 500 and 1000 cells in a sample containing ∼10 5 cells per well in 96-well format.
Screening of 4505 compounds with the AK assay in the 384-well format
In preparation for HTS using the AK assay, we adapted the manual 96-well plate protocol to 384-well format simply by reducing the volume of both the culture and assay reagent solutions (25 μL) and by carrying out the entire process in a standardvolume, white-walled, 384-well plate (for a complete description, see the Materials and Methods section). To validate the 384well protocol, we performed full-plate experiments in which rows alternately contained positive (CAS) and negative controls (1% DMSO). Duplicate plates were tested on 3 separate days, and the results of these experiments are summarized in Table 3 . The standard deviation for both negative (12%) and positive controls (6%) was comparable to the 96-well format, and therefore, the resulting Z′ scores for the 384-well protocol (0.7-0.8) were suitable for HTS. 17, 18 To test the performance of the AK assay protocol in the HTS setting, we screened 5 libraries of small molecules using the 384-well format protocol (see Table 1 for a description of the libraries). Two of the libraries (Bimol and Prestwick) contained molecules with known biological activity (complete lists of the library molecules are available at http://iccb.med.harvard.edu/). Two natural product libraries derived from plant and fungal extracts (NCCDG1) and marine extracts (ICBG6) were also screened as well as a library of isoquinoline-derived molecules (ChemDiv5); the latter library was chosen to test the hit rate of the AK assay with a set of molecules with no known antifungal properties.
Based on our control experiments, the RLU ratio of 5 for treated and untreated wells was chosen as the threshold level for positives. This level of activity corresponds to approximately 2% cell lysis. The AK assay consistently provides a 10% standard deviation, and therefore, an AK signal of 5 also corresponds to a Z′ score of ∼0.5, the minimum suitable for HTS. Each hit was classified as weak (RLU ratio = 5-10), medium (RLU ratio = 10-20), and strong (RLU ratio >20). Each library plate was screened in duplicate and contained both positive and negative controls. The average RLU from the duplicate runs was calculated and used to score the compound as positive or negative.
The results of our HTS experiments are summarized in Table 1 , Table 3 , and Figure 3. Figure 3 shows a plot of AK activity for a representative library plate (plate 1571 from the Prestwick Library of known bioactive compounds) from which 6 positive compounds were identified. Overall, the hit rate for the AK assay was 3.5%, with 45% of the hits classified as either strong or medium and 55% classified as weak ( Table 1) . The majority of the positive molecules were in the 2 libraries of molecules with known biological activity (hit rate = 7.3%). The fewest hits were identified in the ChemDiv5 library of isoquinolines (hit rate = 0.1%), consistent with the paucity of known antifungal molecules with this general structure. A list of all positive-scoring molecules from the 2 libraries of molecules with known biological activity is provided in Supplemental Table 1 . The hit rate for the 2 natural product libraries was 1% for the fungal extract collection and 3% for the marine collection.
As shown in Table 3 (intrascreening statistics column), the analysis of control wells (1% DMSO and CAS) manually added to the library plates during screening showed that the AK assay performed well, with a representative Z′ score (0.78) similar to that obtained during the validation experiments. Each compound was tested in duplicate, and plate-to-plate correlation between the replicates of the same compound was reasonable (average coefficient of variation between the 2 replicates was 15%). Of 87 weak hits, 16 had average values greater than the 5-fold RLU threshold, but 1 of the 2 replicate AK values was less than the 5-fold threshold. Three such hits were among those retested, and 1 of the 3 was confirmed to be positive. Therefore, hit selection criteria that require both replicates to be greater than the 5-fold threshold would yield a more stringent screen, albeit with some loss in sensitivity.
A set of 43 molecules (27% of the hits) were selected for retesting. Cherry picks (CP) were chosen to represent as many of the mechanistic classes identified in the primary screen as possible within the constraints of compound availability. Among the 43 CP, 17 (40%) were weakly active, 14 (33%) were of medium activity, and 12 (28%) were strongly active, a distribution of hit classes similar to that obtained in the primary screen. Thirty-seven CP were confirmed to induce AK release (85%). The false-positive rate for the 3 classes of hits was 24% (4/17) for weak compounds, 14% (2/14) for medium compounds, and 8% (1/12) for strong compounds. There did not appear to be a relationship between mechanism of action and false-positive rate, although this conclusion is tentative because of the relatively small number of compounds retested. We also tested 12 of the 43 (28%) CP molecules using PI staining to confirm that AK release corresponded to cell death (see Supplemental Table 2 online at http://jbx.sagepub.com/supplemental/). All 8 of the molecules confirmed to induce AK also caused cell death as judged by PI staining, whereas the 4 molecules that did not induce AK on retest also did not cause cell death by PI staining. These results further validate the ability of the AK assay to identify molecules that directly kill yeast cells.
DISCUSSION
As an approach to the direct identification of molecules that disrupt yeast cell integrity, we have developed a new HTScompatible assay of yeast cell lysis that performs well with the model yeast S. cerevisiae and the pathogenic yeast C. albicans. The assay is based on the release of AK activity into the growth medium by lysed cells as a reporter of yeast cell lysis. In addition to directly detecting cell lysis, the AK assay has a number of other important features. First, the incubation time (5 h) required for optimal results is much shorter than the overnight to day-long incubations frequently used in traditional growth-based assays of antifungal activity. 11, 16 In principle, this feature could greatly increase throughput in a large-scale screening campaign. Second, the AK assay is able to detect compounds that cause yeast cell lysis at drug concentrations well below those that affect the overall growth rate of the culture. Consequently, the AK assay should detect weakly active lead compounds that could be improved by further medicinal chemistry-based optimization. Similarly, natural products present in low purity or as small fractions of complex mixtures should also be more readily detectable using the AK assay than with a growth-based assay.
Third, the assay is operationally simple and can be performed in a single microplate using standard incubators without need for shaking. Furthermore, it is compatible with standard, unbuffered yeast culture medium (YPD). As a result, the material costs of screening in a 384-well format are approximately $0.07/well based on 2007 catalog prices for all components.
Both control and pilot screening experiments indicate that the AK assay is specific for molecules that cause cell lysis and that it does not detect molecules with fungistatic mechanisms of action. Although this could be seen as a limitation, fungicidal molecules have advantages over fungistatic molecules, particularly in the setting of an immuncompromised patient. Therefore, methods for the direct detection of this valuable class of molecule should be useful tools in antifungal drug discovery.
We have validated the AK assay in the HTS setting through a screen of 5 small-molecule libraries. In addition to giving reasonable hit rates, the AK assay showed a low false-positive rate (15%) and identified molecules with known fungilytic activity. Based on results from 2 libraries of known bioactives ( Table 1) , we classified the mechanism of action of a number of hits ( Table 4 ). As expected, many hits targeted some aspect of membrane biology (40/108) including direct membrane perturbants, ergosterol inhibitors (which directly damage membranes at the concentrations used in the screen 12 ), ion metabolism inhibitors, and fatty acid biosynthesis inhibitors. In addition to membrane-targeted molecules, molecules that target the fungal cell wall integrity also cause yeast cell lysis. 19 The Prestwick and Bimol libraries ( Table 1) also contained 2 known cell wall active molecules, tunicamycin and staurosporine, and both scored positive. 20, 21 Thus, the AK assay identified molecules with mechanisms of action expected to cause cell lysis.
Overall, 66 of 106 hits in the Bimol and Prestwick collections ( Table 1) either were known to have antifungal activity or were close structural analogs of molecules with antifungal properties. The 2 collections had a total of 15 clinically used antifungal drugs, and our screen identified 9 (60%). Of the 6 antifungal drugs not identified in the primary screen, control experiments ( Fig. 1E) had shown that 2 (AMB and 5-fluorocytosine) did not induce AK activity within the 5-h incubation period used in the screen. The other AK-negative antifungals (griseofluvin, eniloconazole, and treconazole) are fungistatic, a finding that further supports the specificity of the AK assay for fungicidal molecules. Taken together, the mechanistic profile of the primary screening hits validates AK-based screening as a highly specific approach for the identification of molecules that disrupt yeast cell integrity.
In summary, we have developed a convenient, low-cost HTS assay to directly screen for molecules that disrupt yeast cell integrity. Although we have focused our initial development efforts on the application of the assay to S. cerevisiae, the assay is also applicable to the human pathogen, C. albicans. Indeed, because AK is a ubiquitous enzyme in yeast and molds, similar methods should be applicable to other fungi such as filamentous or dimorphic human pathogens.
